News | April 28, 2026
From losses to lift-off: Astec gains ground in Q4 FY26
The company reported consolidated total income of Rs. 161.3 crore in Q4 FY26, a strong jump from Rs. 120.3 crore in the same period last year
The company reported consolidated total income of Rs. 161.3 crore in Q4 FY26, a strong jump from Rs. 120.3 crore in the same period last year
Rs. 40 cr buyback, 200% dividend announced
The product is manufactured at AKUMS’ state-of-the-art injectable facility in Kotdwar, Uttarakhand
Deploys $40 million in Hyderabad; advances APIs, peptides, and global small molecule capabilities
The submission is backed by positive results from the Phase 3 AFFIRM study
The lens received U.S. Food and Drug Administration (FDA) market authorization via the De Novo pathway in late 2025
His appointment is expected to strengthen scientific input in policy discussions across public health, biotech, and translational research
Collaboration to drive diagnostics exports, tap high-growth regional markets and build scalable commercialization platform
The deal signals a clear push to expand access to care in underserved regions
The centre will leverage AI-enabled tools to support research and diagnostics for complex eye–brain disorders
Subscribe To Our Newsletter & Stay Updated
